The Scientific Advisory Committee (SAC), composed of international consortium representatives and domain experts, provides strategic and operational guidance for the Pediatric Cancer Data Commons.
- To ensure that the PCDC has an appropriate, sustainable and ethical approach to linking data across diseases and data types (clinical, genomics, imaging, tissues, histology, etc.)
- To build and refine the data commons with clinical, genomic, imaging, tissue, histology, and other data while maintaining the independence of the disease consortia for scientific direction
- To include representative key stakeholders in advising the PCDC
- To maintain the autonomy and scientific direction of the clinical disease consortia